Home RxNorm 1242705 hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1242705
RxNorm name hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev]
Display name NULEV (Oral Disintegrating)
Full name hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev]
Term type SBD
Status Active
Strength 0.125 mg
Dose form Tab
Route Oral Disintegrating
Updated 2026-08-08 11:34:56 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 022012
Active start 022012
Multiple ingredient NO
Branded YES Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength hyoscyamine sulfate 0.125 MG / 1 EACH hyoscyamine hyoscyamine sulfate
Derived Ingredient Concepts# Ingredient, RxCUI table Ingredient RxCUI hyoscyamine 153970
FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 68220-118-10 68220-118 NuLev hyoscyamine sulfate Viatris Specialty LLC
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 8 matching rows.
NDC11, Source, Active table NDC11 Source Active 68220011810 rxnav_ndcs yes 00091311101 rxnav_historical_indirect 00091311199 rxnav_historical_indirect 00131311101 rxnav_historical_indirect 55253011102 rxnav_historical_indirect 55253011106 rxnav_historical_indirect 55253011199 rxnav_historical_indirect 58716094010 rxnav_historical_indirect
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective ae2a78b2-b811-11e2-9e96-0800200c9a66 NuLev 0.125 MG Disintegrating Oral Tablet [PSN] · hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet [Nulev] [SBD] · Nulev 0.125 MG Disintegrating Oral Tablet [SY] 3 6 NuLev ® Chewable Melt Tablets (hyoscyamine sulfate USP) 0.125 mg/tablet 20250715
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective ae2a78b2-b811-11e2-9e96-0800200c9a66 NuLev ® Chewable Melt Tablets (hyoscyamine sulfate USP) 0.125 mg/tablet Viatris Specialty LLC 20250715
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC A03BA Belladonna alkaloids, tertiary amines ATC1-4 hyoscyamine MEDRT D064692 Hyoscyamine CHEM has_ingredient hyoscyamine sulfate MEDRT D064692 Hyoscyamine CHEM has_ingredient hyoscyamine MEDRT D000014 Abnormalities, Drug-Induced DISEASE may_treat hyoscyamine sulfate MEDRT D000014 Abnormalities, Drug-Induced DISEASE may_treat hyoscyamine MEDRT D003085 Colic DISEASE may_treat hyoscyamine MEDRT D003085 Colic DISEASE may_treat hyoscyamine sulfate MEDRT D003093 Colitis, Ulcerative DISEASE ci_with hyoscyamine MEDRT D003093 Colitis, Ulcerative DISEASE ci_with hyoscyamine sulfate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hyoscyamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hyoscyamine sulfate MEDRT D018589 Gastroparesis DISEASE induces hyoscyamine MEDRT D018589 Gastroparesis DISEASE induces hyoscyamine sulfate MEDRT D005901 Glaucoma DISEASE ci_with hyoscyamine sulfate MEDRT D005901 Glaucoma DISEASE ci_with hyoscyamine MEDRT D006945 Hyperhidrosis DISEASE may_treat hyoscyamine sulfate MEDRT D006945 Hyperhidrosis DISEASE may_treat hyoscyamine MEDRT D007077 Ileal Diseases DISEASE ci_with hyoscyamine MEDRT D007077 Ileal Diseases DISEASE ci_with hyoscyamine sulfate MEDRT D007415 Intestinal Obstruction DISEASE ci_with hyoscyamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with hyoscyamine sulfate MEDRT D007431 Intraoperative Complications DISEASE may_treat hyoscyamine MEDRT D007431 Intraoperative Complications DISEASE may_treat hyoscyamine sulfate MEDRT D043183 Irritable Bowel Syndrome DISEASE may_treat hyoscyamine sulfate MEDRT D043183 Irritable Bowel Syndrome DISEASE may_treat hyoscyamine MEDRT D008532 Megacolon, Toxic DISEASE ci_with hyoscyamine MEDRT D008532 Megacolon, Toxic DISEASE ci_with hyoscyamine sulfate MEDRT D009127 Muscle Rigidity DISEASE may_treat hyoscyamine MEDRT D009127 Muscle Rigidity DISEASE may_treat hyoscyamine sulfate MEDRT D009157 Myasthenia Gravis DISEASE ci_with hyoscyamine sulfate MEDRT D009157 Myasthenia Gravis DISEASE ci_with hyoscyamine MEDRT D017202 Myocardial Ischemia DISEASE ci_with hyoscyamine MEDRT D017202 Myocardial Ischemia DISEASE ci_with hyoscyamine sulfate MEDRT D010437 Peptic Ulcer DISEASE may_treat hyoscyamine MEDRT D010437 Peptic Ulcer DISEASE may_treat hyoscyamine sulfate MEDRT D012220 Rhinitis DISEASE may_treat hyoscyamine MEDRT D012220 Rhinitis DISEASE may_treat hyoscyamine sulfate MEDRT D012771 Shock, Hemorrhagic DISEASE ci_with hyoscyamine sulfate MEDRT D012771 Shock, Hemorrhagic DISEASE ci_with hyoscyamine MEDRT D012798 Sialorrhea DISEASE may_treat hyoscyamine sulfate MEDRT D012798 Sialorrhea DISEASE may_treat hyoscyamine MEDRT D013035 Spasm DISEASE may_treat hyoscyamine MEDRT D013035 Spasm DISEASE may_treat hyoscyamine sulfate MEDRT D014202 Tremor DISEASE may_treat hyoscyamine MEDRT D014202 Tremor DISEASE may_treat hyoscyamine sulfate MEDRT D014524 Urethral Obstruction DISEASE ci_with hyoscyamine MEDRT D014524 Urethral Obstruction DISEASE ci_with hyoscyamine sulfate MEDRT D001750 Urinary Bladder, Neurogenic DISEASE may_treat hyoscyamine sulfate MEDRT D001750 Urinary Bladder, Neurogenic DISEASE may_treat hyoscyamine MEDRT D014987 Xerostomia DISEASE induces hyoscyamine MEDRT D014987 Xerostomia DISEASE induces hyoscyamine sulfate MEDRT N0000000125 Cholinergic Muscarinic Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000000125 Cholinergic Muscarinic Antagonists MOA has_moa hyoscyamine MEDRT N0000000207 Histamine Receptor Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000000207 Histamine Receptor Antagonists MOA has_moa hyoscyamine MEDRT N0000000130 Serotonin Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000000130 Serotonin Antagonists MOA has_moa hyoscyamine MEDRT N0000008331 Cardiovascular Activity Alteration PE has_pe hyoscyamine sulfate MEDRT N0000008331 Cardiovascular Activity Alteration PE has_pe hyoscyamine MEDRT N0000008868 Decreased Respiratory Secretions PE has_pe hyoscyamine sulfate MEDRT N0000008868 Decreased Respiratory Secretions PE has_pe hyoscyamine
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.125 MG ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 NAMES Prescribable Synonym NuLev 0.125 MG Disintegrating Oral Tablet SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon